Spetzler David Baxley bought CAI
March 6, 2026 · Form 4 insider transaction
Spetzler David Baxley bought 83,162 shares of Caris Life Sciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
83,162
Price
$0.00
Total value
N/A
InsiderSpetzler David Baxley
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMarch 6, 2026
Filing dateMarch 10, 2026
Shares owned after543,939
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents an award of restricted stock units which vest in accordance with the applicable grant agreement.